Initial clinical manifestations in a young male with RFX6-variant-associated diabetes.

IF 1 Q4 ENDOCRINOLOGY & METABOLISM
Clinical Pediatric Endocrinology Pub Date : 2024-10-01 Epub Date: 2024-07-20 DOI:10.1297/cpe.2024-0016
Kazuhisa Akiba, Hiroaki Zukeran, Yukihiro Hasegawa, Maki Fukami
{"title":"Initial clinical manifestations in a young male with <i>RFX6</i>-variant-associated diabetes.","authors":"Kazuhisa Akiba, Hiroaki Zukeran, Yukihiro Hasegawa, Maki Fukami","doi":"10.1297/cpe.2024-0016","DOIUrl":null,"url":null,"abstract":"<p><p>To date, heterozygous loss-of-function variants of <i>RFX6</i> have been identified in 13 families with diabetes. Here, we present initial clinical information regarding a young male with diabetes who carried a heterozygous nonsense variant of <i>RFX6</i> (p.Arg377Ter) previously reported in his family with diabetes. At 11 yr and 7 mo of age, the patient experienced severe thirst and hyperglycemia (331-398 mg/dL). Laboratory tests revealed elevated levels of glycated hemoglobin (HbA1c) (47 mmol/mL, 6.5%) and the Homeostatic Model for Insulin Resistance (HOMA-IR) (3.4). Blood glucose self-monitoring demonstrated grossly normal blood glucose levels, together with occasional postprandial hyperglycemia, and a few episodes of hypoglycemia. An oral glucose tolerance test revealed mild hyperglycemia and a delayed peak insulin level. His laboratory indices improved over two years with self-control of diet and exercise. These results indicate that the initial presentation of <i>RFX6</i>-variant-associated diabetes includes occasional hyperglycemia and hypoglycemia in response to changes in lifestyle. The possible association between <i>RFX6</i> variants and mild insulin resistance requires further validation in future studies.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11442700/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pediatric Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1297/cpe.2024-0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

To date, heterozygous loss-of-function variants of RFX6 have been identified in 13 families with diabetes. Here, we present initial clinical information regarding a young male with diabetes who carried a heterozygous nonsense variant of RFX6 (p.Arg377Ter) previously reported in his family with diabetes. At 11 yr and 7 mo of age, the patient experienced severe thirst and hyperglycemia (331-398 mg/dL). Laboratory tests revealed elevated levels of glycated hemoglobin (HbA1c) (47 mmol/mL, 6.5%) and the Homeostatic Model for Insulin Resistance (HOMA-IR) (3.4). Blood glucose self-monitoring demonstrated grossly normal blood glucose levels, together with occasional postprandial hyperglycemia, and a few episodes of hypoglycemia. An oral glucose tolerance test revealed mild hyperglycemia and a delayed peak insulin level. His laboratory indices improved over two years with self-control of diet and exercise. These results indicate that the initial presentation of RFX6-variant-associated diabetes includes occasional hyperglycemia and hypoglycemia in response to changes in lifestyle. The possible association between RFX6 variants and mild insulin resistance requires further validation in future studies.

一名患有 RFX6 变异相关糖尿病的年轻男性的初期临床表现。
迄今为止,已在 13 个糖尿病家族中发现了 RFX6 的杂合功能缺失变体。在此,我们提供了一名年轻男性糖尿病患者的初步临床信息,该患者携带的 RFX6 杂合子无义变体(p.Arg377Ter)曾在其糖尿病家族中报道过。患者在 11 岁零 7 个月时出现严重口渴和高血糖(331-398 毫克/分升)。实验室检测显示糖化血红蛋白(HbA1c)水平升高(47 mmol/mL,6.5%),胰岛素抵抗稳态模型(HOMA-IR)水平升高(3.4)。血糖自我监测显示血糖水平基本正常,偶尔会出现餐后高血糖和几次低血糖。口服葡萄糖耐量试验显示轻度高血糖和胰岛素峰值延迟。经过两年的饮食和运动自我控制,他的实验室指标有所改善。这些结果表明,RFX6变异型相关糖尿病的最初表现包括偶尔的高血糖和因生活方式改变而出现的低血糖。RFX6变异与轻度胰岛素抵抗之间可能存在的关联需要在今后的研究中进一步验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Pediatric Endocrinology
Clinical Pediatric Endocrinology ENDOCRINOLOGY & METABOLISM-
CiteScore
2.40
自引率
7.10%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信